The measurement of acetanilide in plasma by spectrophotometric and selected ion monitoring methods.
Plasma samples from volunteers who had received an oral dose of acetanilide have been analysed by gas chromatography mass spectrometry and ultraviolet absorption techniques. The gas chromatography mass spectrometry method involved extraction of the plasma and analysis of the acetanilide using selected ion monitoring with a deuterated internal standard. In the ultraviolet method the plasma was hydrolysed with acid to convert the acetanilide to aniline, and this compound was diazotized and coupled with N-1-naphthylethylene-diamine. The absorbance of the resulting complex was read at 550 nm. Acetanilide levels in plasma determined by the selected ion monitoring method were significantly lower than those measured by spectrophotometry. Pharmacokinetic data calculated from the results obtained using these two assays are very different and illustrate the need for an accurate and specific method of analysis. The major metabolites of acetanilide are shown not to interfere with these assays and the results suggest the possible presence of a new metabolite of acetanilide.
D000083:Acetanilides / Q000097:blood*; D001702:Biopharmaceutics; D006207:Half-Life; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods*; D012044:Regression Analysis; D013056:Spectrophotometry, Ultraviolet / Q000379:methods*
D000083:Acetanilides